Overview
- 2 inspections across 2 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-05-24.
At a glance
Inspections
2
Sites
2
Observations
4
Career since
Aug 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Bend Inc. | 24 May 2023 | Human Drugs | View 483 → |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd | 23 Aug 2018 | Human Drugs | On file |
Sites inspected
Lonza Bend Inc.Bend, United States1 insp.
Hangzhou Zhongmei Huadong Pharmaceutical Co., LtdHangzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Hung H Do1 shared
Christopher T Middendorf1 shared
Full investigator report
Get the verbatim findings behind Huiquan Wu's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site